Seeking Alpha

GNMSF
  Genmab A/S - Grey Market

8/21/2014, 6:24 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
GNMSF vs. ETF Alternatives
Company Description
Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.
Sector: Technology
Industry: Biotechnology
Country: Denmark